These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2567525)

  • 1. An hypothesis regarding the antipsychotic effect of neuroleptic drugs.
    Freed WJ
    Pharmacol Biochem Behav; 1989 Jan; 32(1):337-45. PubMed ID: 2567525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic latency of neuroleptic drugs and nonspecific postjunctional supersensitivity.
    Freed WJ
    Schizophr Bull; 1988; 14(2):269-77. PubMed ID: 2904695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of dopaminergic supersensitivity after a single dose of the neuroleptic isofloxythepin.
    Valchár M; Metysová J; Chlebounová J; Dlabac A
    Psychopharmacology (Berl); 1982; 76(4):381-4. PubMed ID: 6126896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions.
    Murrin LC; Gale K; Kuhar MJ
    Eur J Pharmacol; 1979 Dec; 60(2-3):229-35. PubMed ID: 43260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical mechanism of action of neuroleptics (author's transl)].
    Scatton B
    Encephale; 1981; 7(3):201-14. PubMed ID: 6116590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.
    Julou L; Scatton B; Glowinski J
    Adv Biochem Psychopharmacol; 1977; 16():617-24. PubMed ID: 18904
    [No Abstract]   [Full Text] [Related]  

  • 7. Glutamatergic mechanisms mediating stimulant and antipsychotic drug effects.
    Freed WJ
    Neurosci Biobehav Rev; 1994; 18(1):111-20. PubMed ID: 7909593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.
    Chouinard G; Jones BD
    Am J Psychiatry; 1980 Jan; 137(1):16-21. PubMed ID: 6101522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum.
    Boyson SJ; McGonigle P; Luthin GR; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1988 Mar; 244(3):987-93. PubMed ID: 2908050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molindone hydrochloride: a review of laboratory and clinical findings.
    Owen RR; Cole JO
    J Clin Psychopharmacol; 1989 Aug; 9(4):268-76. PubMed ID: 2671060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of chronic neuroleptic administration on cerebral dopamine receptor function.
    Rupniak MN; Jenner P; Marsden CD
    Life Sci; 1983 May; 32(20):2289-311. PubMed ID: 6133203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
    Arushanian EB
    Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic pharmacological manipulation of dopamine receptors in brain.
    Jenner P; Marsden CD
    Neuropharmacology; 1987 Jul; 26(7B):931-40. PubMed ID: 2889159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance P.
    Oblin A; Zivkovic B; Bartholini G
    Eur J Pharmacol; 1984 Oct; 105(1-2):175-7. PubMed ID: 6208042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants.
    Rioux L; Gaudin DP; Gagnon C; Di Paolo T; Bédard PJ
    Neuroscience; 1991; 44(1):75-83. PubMed ID: 1770999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Oblin A; Fage D; Scatton B
    Eur J Pharmacol; 1983 Sep; 93(1-2):55-62. PubMed ID: 6628547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P; Mercuri NB; Sancesario G; Bernardi G
    Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.